封面
市場調查報告書
商品編碼
1948712

富勒烯市場-全球產業規模、佔有率、趨勢、機會、預測:按類型、最終用戶、地區和競爭格局分類,2021-2031年

Fullerene Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (C60, C70, C76, Others), By End User (Electrical and Electronics, Pharmaceuticals, Medical, Energy, and Others), By Region & Competition, 2021-2031F

出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球富勒烯市場預計將從 2025 年的 5.8 億美元成長到 2031 年的 8.7 億美元,複合年成長率為 6.99%。

該市場專注於具有中空籠狀結構的特殊碳同素異形體,其中球形C60分子尤其以其優異的抗張強度、導電性和抗氧化性能而聞名。推動市場成長的關鍵因素包括富勒烯在醫療領域靶向藥物遞送和抗病毒療法中的應用日益廣泛,以及其在電子行業高效有機太陽能電池和半導體製造中的關鍵作用。這些因素標誌著該材料效用的根本性轉變,意味著富勒烯在高精度應用中的性能優於傳統化合物。

市場概覽
預測期 2027-2031
市場規模:2025年 5.8億美元
市場規模:2031年 8.7億美元
複合年成長率:2026-2031年 6.99%
成長最快的細分市場 電氣和電子設備
最大的市場 亞太地區

儘管富勒烯具有這些優勢,但市場仍面臨許多挑戰,包括商業規模合成和純化的高成本和複雜性,這阻礙了其在行業的廣泛應用。生產製程技術要求極高,通常需要複雜的步驟才能從原始煙塵中分離出特定的富勒烯種類。然而,該領域的商業性成熟度顯而易見;據奈米技術產業協會稱,美國環保署在2024年審查了約300份奈米級材料(包括富勒烯)的生產前通知。這項活動表明,儘管存在生產障礙,但產業發展仍在繼續,並凸顯了為克服規模化障礙並將這些尖端材料整合到消費品和工業產品中而做出的持續努力。

市場促進因素

富勒烯在標靶藥物傳遞和治療領域的應用日益廣泛,是推動市場發展的主要動力。這些材料在封裝活性藥物成分和清除自由基方面展現出卓越的性能。其獨特的碳籠結構能夠實現藥物精準遞送,突破生物屏障,從而有助於解決腫瘤學和抗病毒治療領域的一些難題。這項生物醫學潛力得到了聯邦政府的大力支持。根據美國國家奈米技術協調辦公室2024年12月發布的報告《總統2025會計年度預算國家奈米技術舉措補充文件》,美國國立衛生研究院每年在基於奈米技術的診斷和治療技術方面投入超過9億美元。如此大規模的投資凸顯了這些材料在下一代醫學中的重要性,並且正在加速其臨床應用。

此外,有機太陽能電池和太陽能應用領域的拓展正在刺激市場需求,這主要歸功於富勒烯作為有機和鈣鈦礦太陽能電池中電子受體的高效性。製造商正在增加富勒烯衍生物的使用,以改善電荷傳輸性能和裝置穩定性,整個產業也正從實驗室研究轉向商業化生產。這種產業結構的轉變體現在策略整合中,例如三菱商事株式會社於2024年4月宣布與DENKA COMPANY LIMITED株式會社就富勒烯業務達成合資協議。三菱商事株式會社將其持有的Frontier Carbon Corporation 50%的股份轉讓給了DENKA COMPANY LIMITED株式會社,旨在利用雙方的聯合能力促進能源領域的成長。更廣泛的研究獎勵進一步推動了這項商業性發展動能。根據美國國家奈米技術舉措(NNI)2024年的一份報告,美國總統在2025會計年度預算提案中申請了超過22億美元的NNI撥款,以確保基礎奈米材料研究持續取得進展所需的資源。

市場挑戰

商業規模的合成和純化成本高且技術複雜,是全球富勒烯市場擴張的主要障礙。高純度富勒烯的生產需要高能耗方法,例如電弧放電,這往往會導致難以分離且高成本的同素異形體混合物。這種低效性推高了材料的最終價格,削弱了富勒烯在成本敏感型應用(例如大規模生產的有機太陽能電池)中的經濟可行性,迫使製造商選擇效率較低但價格更低的替代品。

這種規模化生產的停滯也反映在近期的工業活動水準。根據奈米技術產業協會(NAAA)統計,截至2024年,美國環保署(EPA)僅審查了14項奈米級材料的預生產通知。與以往累積數據相比,新申請數量的低迷表明,製造商不願投資開發高成本的新型富勒烯變體和生產線。這些數據凸顯了提純過程中存在的財務和技術障礙正直接阻礙新型商業材料的推出,有效地將市場限制在高利潤、低銷售的細分領域。

市場趨勢

將封裝富勒烯開發為磁振造影(MRI)造影劑正成為一項突破性趨勢,使這些材料從實驗室稀有物質轉變為商業性可行性的診斷工具。傳統上,金屬富勒烯(例如將钆等金屬原子封裝在碳籠中)的合成一直受到高昂製造成本的限制,儘管它們與傳統造影劑相比具有更高的解析度和更低的毒性,但其在放射學領域的應用仍受到限制。然而,工業技術的最新進展最終使這些化合物的大規模生產成為可能。根據 2025 年 1 月 InvestorNews 的報告《Voyageur 總結 2024 年主要成就並宣布 2025 年變革性計劃》,氮摻雜封裝富勒烯(此前每克價值約 1.67 億美元)如今正憑藉新的大規模合成技術打破這一壁壘,加速進入市場。

同時,芴酮C60在高階抗衰老化妝品的應用正在加速成長。其強大的抗氧化能力是推動這一趨勢的主要因素,尤其是在亞洲市場。為了應對氧化壓力引起的皮膚老化問題,化妝品製造商正從傳統成分轉向水溶性芴酮衍生物,以滿足日益成長的、具有科學意識的消費者的需求。這項應用也得到了臨床證據的支持,這些證據表明其具有卓越的功效。根據2025年1月發表在in-cosmetics Connect上的報導《富勒烯的優勢:來自日本的抗衰老》,富勒烯的抗氧化效果是維生素C的250倍以上。儘管配方技術複雜,但這項性能指標仍然是促使品牌將這些化合物添加到高階精華液的決定性因素。

目錄

第1章概述

第2章:調查方法

第3章執行摘要

第4章:客戶心聲

第5章:全球富勒烯市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按類型(C60、C70、C76、其他)
    • 按最終用戶(電氣和電子設備、製藥、醫療、能源、其他)
    • 按地區
    • 按公司(2025 年)
  • 市場地圖

第6章:北美富勒烯市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲:國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章:歐洲富勒烯市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲:國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章:亞太地區富勒烯市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區:國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章:中東和非洲富勒烯市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲:國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章:南美洲富勒烯市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲:國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章:全球富勒烯市場:SWOT分析

第14章:波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Nano-C, Inc.
  • SES AI Corporation.
  • Mitsubishi Chemical Corporation
  • Merck KGaA
  • MTR Corporation Limited.
  • Nanostructured & Amorphous Materials, Inc.
  • Xiamen Funano New Material Technology Co., Ltd.
  • Tokyo Chemical Industry UK Ltd
  • Sisco Research Laboratories Pvt. Ltd.
  • Otto Chemie Pvt Ltd

第16章 策略建議

第17章:關於研究公司及免責聲明

簡介目錄
Product Code: 15118

The Global Fullerene Market is projected to expand from USD 0.58 Billion in 2025 to USD 0.87 Billion by 2031, registering a CAGR of 6.99%. This market focuses on a specialized category of carbon allotropes defined by their hollow, cage-like structures, particularly the spherical C60 molecule, which is renowned for its tensile strength, electrical conductivity, and antioxidant properties. The primary factors driving growth include the rising use of fullerenes in the medical field for targeted drug delivery and antiviral treatments, as well as their essential role in the electronics sector for creating efficient organic photovoltaics and semiconductors. These drivers denote a fundamental shift in material utility, where fullerenes provide superior performance compared to traditional compounds in high-precision applications.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 0.58 Billion
Market Size 2031USD 0.87 Billion
CAGR 2026-20316.99%
Fastest Growing SegmentElectrical and Electronics
Largest MarketAsia Pacific

Despite these strengths, the market contends with significant challenges regarding the high cost and complexity of commercial-scale synthesis and purification, which hinders broad industrial adoption. Production is technically rigorous, often involving intricate processes to separate specific fullerene types from raw soot. However, the sector's commercial maturity remains evident; according to the Nanotechnology Industries Association, the regulatory landscape in 2024 showed that the U.S. Environmental Protection Agency had reviewed roughly 300 premanufacture notices for nanoscale materials, including fullerenes. This activity indicates sustained industrial development despite manufacturing hurdles, highlighting a continued effort to overcome scalability barriers and integrate these advanced materials into consumer and industrial products.

Market Driver

The rising adoption of fullerenes in targeted drug delivery and therapeutics is a major force driving the market, as these materials demonstrate exceptional capabilities in encapsulating active pharmaceutical ingredients and scavenging free radicals. Their unique carbon cage structure facilitates the precise transport of therapeutic agents across biological barriers, addressing difficult challenges in oncology and antiviral treatments. This biomedical potential is underpinned by substantial federal funding; according to the National Nanotechnology Coordination Office's December 2024 report on the 'National Nanotechnology Initiative Supplement to the President's 2025 Budget', the National Institutes of Health invests over $900 million annually in nanotechnology-enabled diagnostic and therapeutic technologies. Such significant capital infusion confirms the material's critical role in next-generation medicine and accelerates its clinical translation.

Additionally, the expansion of organic photovoltaics and solar energy applications is stimulating market demand, driven by the material's effectiveness as an electron acceptor in organic and perovskite solar cells. Manufacturers are increasingly using fullerene derivatives to improve charge transport and device stability, transitioning from laboratory research to commercial-scale production. This industrial shift is marked by strategic consolidations; according to Mitsubishi Corporation in April 2024, regarding the 'MC and Denka Sign J/V Agreement in Fullerene Business', the company transferred a 50% stake in Frontier Carbon Corporation to Denka Company Limited to leverage collective capabilities for growth in the energy sector. This commercial momentum is further supported by broader research incentives, as the National Nanotechnology Initiative reported in 2024 that the U.S. President's 2025 Budget requested over $2.2 billion for the NNI to ensure continued resources for foundational nanomaterial advancements.

Market Challenge

The prohibitive cost and technical complexity associated with commercial-scale synthesis and purification create a formidable barrier to the expansion of the Global Fullerene Market. Producing high-purity fullerenes necessitates energy-intensive methods, such as arc discharge, which frequently result in a mixture of allotropes that are difficult and expensive to separate. This inefficiency increases the final price of the material, rendering fullerenes economically unviable for cost-sensitive applications like mass-market organic photovoltaics, thereby forcing manufacturers to select cheaper, though less efficient, alternatives.

This stagnation in scalability is mirrored in recent industrial activity levels. According to the Nanotechnology Industries Association, in 2024, the U.S. Environmental Protection Agency had only 14 premanufacture notices for nanoscale materials actively under review. This low volume of new applications, relative to historical cumulative figures, suggests a hesitation among manufacturers to invest in the costly development of new fullerene variants or production lines. The data highlights that the financial and technical hurdles of purification are directly stifling the introduction of new commercial-grade materials, effectively confining the market to high-margin, low-volume niches.

Market Trends

The development of endohedral fullerenes for Magnetic Resonance Imaging contrast is emerging as a transformative trend, shifting these materials from laboratory curiosities to commercially viable diagnostic tools. Historically, the synthesis of metallofullerenes-where metal atoms like gadolinium are encapsulated within the carbon cage-was hindered by astronomical production costs, preventing their use in radiology despite their potential for superior resolution and lower toxicity compared to traditional agents. Recent industrial advancements have finally enabled the scalable manufacturing of these compounds; according to InvestorNews in January 2025, in the 'Voyageur Recaps Significant 2024 Achievements and Unveils Plans for Transformational 2025' report, nitrogen-doped endohedral fullerenes were previously valued at approximately $167 million per gram, a barrier that new large-scale synthesis technologies are now successfully dismantling to facilitate market entry.

Simultaneously, the proliferation of Fullerene C60 in premium anti-aging cosmetics is accelerating, particularly within Asian markets, driven by the material's potent antioxidative capacity. Cosmetic manufacturers are increasingly replacing conventional ingredients with water-soluble fullerene derivatives to address skin aging caused by oxidative stress, appealing to a growing segment of science-focused consumers. This adoption is supported by clinical evidence of superior efficacy; according to in-cosmetics Connect in January 2025, in the article 'Why Fullerene? Anti-ageing made in Japan', fullerene ingredients demonstrate an antioxidant effect more than 250 times that of vitamin C, a performance metric that is compelling brands to integrate these compounds into high-value serums despite the technical complexity of formulation.

Key Market Players

  • Nano-C, Inc.
  • SES AI Corporation.
  • Mitsubishi Chemical Corporation
  • Merck KGaA
  • MTR Corporation Limited.
  • Nanostructured & Amorphous Materials, Inc.
  • Xiamen Funano New Material Technology Co., Ltd.
  • Tokyo Chemical Industry UK Ltd
  • Sisco Research Laboratories Pvt. Ltd.
  • Otto Chemie Pvt Ltd

Report Scope

In this report, the Global Fullerene Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Fullerene Market, By Type

  • C60
  • C70
  • C76
  • Others

Fullerene Market, By End User

  • Electrical and Electronics
  • Pharmaceuticals
  • Medical
  • Energy
  • Others

Fullerene Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Fullerene Market.

Available Customizations:

Global Fullerene Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Fullerene Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (C60, C70, C76, Others)
    • 5.2.2. By End User (Electrical and Electronics, Pharmaceuticals, Medical, Energy, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Fullerene Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Fullerene Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Fullerene Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Fullerene Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By End User

7. Europe Fullerene Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Fullerene Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By End User
    • 7.3.2. France Fullerene Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By End User
    • 7.3.3. United Kingdom Fullerene Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Fullerene Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Fullerene Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By End User

8. Asia Pacific Fullerene Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Fullerene Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By End User
    • 8.3.2. India Fullerene Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By End User
    • 8.3.3. Japan Fullerene Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By End User
    • 8.3.4. South Korea Fullerene Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia Fullerene Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By End User

9. Middle East & Africa Fullerene Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Fullerene Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By End User
    • 9.3.2. UAE Fullerene Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By End User
    • 9.3.3. South Africa Fullerene Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By End User

10. South America Fullerene Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Fullerene Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By End User
    • 10.3.2. Colombia Fullerene Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By End User
    • 10.3.3. Argentina Fullerene Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Fullerene Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Nano-C, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. SES AI Corporation.
  • 15.3. Mitsubishi Chemical Corporation
  • 15.4. Merck KGaA
  • 15.5. MTR Corporation Limited.
  • 15.6. Nanostructured & Amorphous Materials, Inc.
  • 15.7. Xiamen Funano New Material Technology Co., Ltd.
  • 15.8. Tokyo Chemical Industry UK Ltd
  • 15.9. Sisco Research Laboratories Pvt. Ltd.
  • 15.10. Otto Chemie Pvt Ltd

16. Strategic Recommendations

17. About Us & Disclaimer